- Home
- SILC vs TELA Comparison
SILC vs TELA Comparison
Compare SILC & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILC
- TELA
- Stock Information
- Founded
- SILC 1987
- TELA 2012
- Country
- SILC Israel
- TELA United States
- Employees
- SILC N/A
- TELA N/A
- Industry
- SILC Computer Manufacturing
- TELA Medical/Dental Instruments
- Sector
- SILC Technology
- TELA Health Care
- Exchange
- SILC Nasdaq
- TELA Nasdaq
- Market Cap
- SILC 86.2M
- TELA 70.1M
- IPO Year
- SILC 1994
- TELA 2019
- Fundamental
- Price
- SILC $16.50
- TELA $1.77
- Analyst Decision
- SILC Hold
- TELA Buy
- Analyst Count
- SILC 1
- TELA 3
- Target Price
- SILC N/A
- TELA $5.33
- AVG Volume (30 Days)
- SILC 20.3K
- TELA 97.6K
- Earning Date
- SILC 07-31-2025
- TELA 08-11-2025
- Dividend Yield
- SILC N/A
- TELA N/A
- EPS Growth
- SILC N/A
- TELA N/A
- EPS
- SILC N/A
- TELA N/A
- Revenue
- SILC $58,651,000.00
- TELA $75,323,000.00
- Revenue This Year
- SILC $6.53
- TELA $25.72
- Revenue Next Year
- SILC $14.10
- TELA $22.03
- P/E Ratio
- SILC N/A
- TELA N/A
- Revenue Growth
- SILC N/A
- TELA 16.34
- 52 Week Low
- SILC $12.29
- TELA $0.86
- 52 Week High
- SILC $18.61
- TELA $3.26
- Technical
- Relative Strength Index (RSI)
- SILC 55.22
- TELA 51.41
- Support Level
- SILC $15.03
- TELA $1.70
- Resistance Level
- SILC $16.49
- TELA $2.00
- Average True Range (ATR)
- SILC 0.61
- TELA 0.19
- MACD
- SILC 0.02
- TELA 0.02
- Stochastic Oscillator
- SILC 89.74
- TELA 65.83
About SILC Silicom Ltd
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.